Detection and Volumetry of Pulmonary Nodules on Ultra-low Dose Chest CT Scan With Deeplearning Image Reconstruction Algorithm (DLIR)

Pulmonary Nodules, Multiple Clinical Trial

— DLIRTHORAX  

Official title:

Detection and Volumetry of Pulmonary Nodules on Ultra-low Dose Chest CT Scan With Deeplearning Image Reconstruction Algorithm (DLIR)

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT04482114
• Other study ID #: PI2020_843_0052
• Status: Active, not recruiting
• Phase: N/A
• Start date: July 22, 2020
• Est. completion date: July 2023

Study information

• Verified date: March 2023
• Source: Centre Hospitalier Universitaire, Amiens
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

evaluate the diagnostic performance of ultra-low dose CT using deep learning-based reconstruction in the detection of pulmonary nodules.

Description:

• Background: Lung cancer is the leading cause of cancer deaths. Patients with pulmonary nodules often undergo multiple computed tomography (CT) examinations for diagnostic and follow-up purposes.

• Purpose: The main objective of this study is to evaluate the diagnostic performance of ultra-low dose CT using deep learning-based reconstruction in the detection of pulmonary nodules.

• Abstract: Despite recent advances, lung cancer remains the most commonly diagnosed cancer and the leading cause of cancer death worldwide because it is often diagnosed at advanced stages that are not surgically curable. Nevertheless, early detection of lung cancer allows surgical resection, offers curative treatment and the best chance of survival. There is currently no screening program in France, but individual screening can be carried out depending on risk factors. Many pulmonary nodules are discovered each year, most of which are benign. The challenge is to distinguish malignant lesions from the multitude of benign lesions. One of the most effective criteria is the doubling time of the nodules which leads to multiple follow-up examinations requiring ionizing radiation to assess the size and growth of the nodules. Great efforts are currently being made by CT manufacturers in order to reduce the radiation with equivalent diagnostic performance. Patients who were referred to our department for an unenhanced low-dose chest CT (LD CT) for pulmonary nodules check-up or follow-up, and had consented to participate in the study, will undergo an additional ultra-low dose acquisition (ULDCT, <0,25 mSv, similar to standard two-view chest X-Ray) with deep learning-based reconstruction (DLIR). The main objective of this study is to evaluate the diagnostic performance between ULD and LD CT protocols for the detection of pulmonary nodules. The impact of dose reduction will be assessed in this context. The data from each examination will be blindly interpreted from the results of the other one. No follow-up will be required for the study.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 70
• Est. completion date: July 2023
• Est. primary completion date: July 1, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age = 18 years old,

• Patient referred for non-enhanced chest CT for lung nodule check-up or follow-up,

• Affiliation to a social security program,

• Ability of the subject to understand and express opposition

Exclusion Criteria:

• Age <18 years old,

• Person under guardianship or curatorship,

• Pregnant woman,

• Any contraindications to CT

Related Conditions & MeSH terms

• Multiple Pulmonary Nodules
• Pulmonary Nodules, Multiple

Intervention

Radiation:
• ULD CT
All the examinations are part of the routine care. Addition of the ULD CT protocol does not require injection of contrast agent and does not extend the duration of the examination.

Locations

Country	Name	City	State
France	CHU Amiens-Picardie	Amiens

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire, Amiens

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Diagnostic accuracy	The study aimed to investigate the diagnostic accuracy (Sensibility and Specificity) of ultra-low dose CT using DLIR reconstruction for the detection of pulmonary nodules in comparison with the low dose CT reference protocol.	Day 0
Secondary	Image quality	The signal-to-noise ratio or SNR is calculated on areas of interest placed manually on the image (pulmonary parenchyma, axillary fat and surrounding air).; This ratio is calculated by the average signal strength in these areas, divided by the standard deviation of the signal in outdoor areas such as the surrounding air.; The quality of the image is estimated by a score ranging from 0 (poor quality) to 3 (excellent quality) determined subjectively by the operator.	Day 0
Secondary	Pulmonary nodules volume	Difference of pulmonary nodules volume between images acquired at low dose CT and ultra-low dose CT.	Day 0